Accreditation

Target Audience

This symposium is designed for physicians, advanced practice registered nurses, nurses and allied health professionals in the fields of electrophysiology, cardiology, family and internal medicine.

Learning Objectives

Upon completion of this activity, learners will be able to:

• Compare and contrast DOACs for efficacy and safety, while emphasizing the patient populations for whom they are best suited.
• Review evidence-based guidelines and best clinical approaches to thromboprophylaxis.
• Assess the cost-effectiveness of systemic anticoagulation versus LAA exclusion technologies for stroke prophylaxis.
• Review the role of oral anticoagulation in stroke prophylaxis.
• Describe systemic thromboembolization and the role of LAA in patients with atrial fibrillation.
• Express a working knowledge of the role(s) of LAA in specific patient subgroups (ie, OAC treatment-(in)eligible, prescription failure).
• Discuss treatment options for the management of postoperative pericardial inflammation.
• Identify needle devices which can be utilized in specific patients to minimize complications associated with epicardial access.
• Review device types and techniques which may be employed to mitigate an incomplete LAA closure.

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and International Symposium on Left Atrial Appendage Foundation (ISLAA). ACHL is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Academy for Continued Healthcare Learning designates this live activity for a maximum of 17.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion as AAPA, AANP, and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.

Provider approved by the California Board of Registered Nursing, Provider Number 17273 for 17.0 contact hours.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 17.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

By providing your ABIM Diplomate number, you consent to have ACHL and/or our educational partners submit your participation in this activity to the ABIM through the ACCME PARS system. ABIM credit will be submitted to PARS on the first day of each month.

Planning Committee

Donita Atkins, RN, BSN, CCRC, Kansas City Heart Rhythm Institute, Overland Park, KS

David R. Holmes, MD, FACC, FSCAI, Mayo Clinic, Rochester, MN

Saibal Kar, MD, FACC, FSCAI, Los Robles Medical Center, Los Robles, CA

Dhanunjaya Lakkireddy, MD, FACC, FHRS, Kansas City Heart Rhythm Institute, Overland Park, KS

Andrea Natale, MD, FACC, FHRS, FESC, Texas Cardiac Arrhythmia Institute, Austin, TX

Vivek Reddy, MD, Mount Sinai Hospital, New York, NY

Disclaimer

The content of this activity was developed independently of any ineligible company. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantors.

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for use under discussion.

Disclosures

The Academy for Continued Healthcare Learning (ACHL) requires that the faculty and planners participating in an accredited continuing education activity disclose all affiliations or other financial relationships within 24 months (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any ineligible companies. All relevant financial relationships have been mitigated prior to this activity.

For a list of financial disclosures, please visit www.islaasymposium.com/

Providership

Provided by the International Symposium on Left Atrial Appendage Foundation (ISLAA) and the Academy for Continued Healthcare Learning (ACHL) in collaboration with course directors from the Kansas City Heart Rhythm Institute, Texas Cardiac Arrhythmia Institute, Los Robles Medical Center, Mayo Clinic and Mt. Sinai.

Commercial Support

This symposium is supported by educational grants from Boston Scientific, Abbott, J&J Med Tech, Conformal, AtriCure, Lifetech Scientific, Medtronic.